Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 1;24(7):2329-2335.
doi: 10.31557/APJCP.2023.24.7.2329.

The MAGE A1-A10 Expression associated with Histopathological Findings of Malignant or Non-Malignant Cells in Peripheral Lung Tumors

Affiliations

The MAGE A1-A10 Expression associated with Histopathological Findings of Malignant or Non-Malignant Cells in Peripheral Lung Tumors

Gondo Mastutik et al. Asian Pac J Cancer Prev. .

Abstract

Objective: The objective was to evaluate the expression of melanoma antigen (MAGE) A from A1 to 10 (A1-10) and the individual MAGE A family in the peripheral lung tumors and to analyze its association with histopathological findings.

Methods: A cross-sectional study was conducted on 67 samples of peripheral lung tumor obtained by core biopsies from patients with clinical diagnoses such as lung and mediastinal tumors. The specimens were divided into two, one to perform histopathological diagnosis and the last for mRNA MAGE A examination. A Nested polymerase chain reaction (PCR) was performed using universal primer, MF10/MR10 and MF10/MR12. The collected data were analyzed by appropriate statistical techniques.

Result: The histopathological finding showed 41 (61.2 %) of specimens as malignant cells and 26 (38.8 %) of specimens as non-malignant cells. MAGE A1-10 was expressed at 47 (70.1 %) and MAGE A1-6 was expressed at 25 (37.3 %) of specimens. In a malignant cell, MAGE A1-10 and MAGE A1-6 were expressed at 33 (80.5 %) and 19 (46.3 %), respectively. In non-malignant cells, MAGE A1-10 and MAGE A1-6 were expressed at 14 (53.9 %) and 6 (23.1 %,) respectively. The MAGE A1-10 and MAGE A8 expressions were significantly associated with histopathological findings of malignant or non-malignant cells. The sensitivity, specificity, and diagnostic accuracy of MAGE A1-10 were 80.5 %, 46.2 %, and 67.2 %, respectively; while for MAGE A8 were 41.5 %, 88.5 %, and 59.7 %, respectively.

Conclusion: The MAGE A1-10 expression was the most commonly detected and associated with the histopathological finding. Moreover, it was more sensitive and specific and had higher diagnostic accuracy than others. Therefore, the MAGE A1-10 assay may improve the accuracy of the diagnosis of malignancy in peripheral lung tumors.

Keywords: Lung cancer; MAGE A1-10; MAGE A1-6; cancer cell; core biopsy.

PubMed Disclaimer

Conflict of interest statement

All authors have no potential conflict of interest to disclose.

Figures

Figure 1
Figure 1
Histopathological Diagnosis of Lung Tumors. (A) Non-small cell lung cancer type adenocarcinoma and (B) Non-small cell lung cancer type squamous cell carcinoma observed with a light microscope, magnification 100x

Similar articles

Cited by

References

    1. Almutairi MH, Alotaibi MM, Alonaizan R, et al. Identification of MAGE-A family genes in colon cancer patients and their expression mechanism. J King Saud Univ-Sci. 2022;34:102251.
    1. Beppu S, Ito Y, Fujii K, et al. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma. Histopathology. 2017;71:305–15. - PubMed
    1. Brisam M, Rauthe S, Hartmann S, et al. Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma. Oncol Rep. 2016;35:1979–86. - PubMed
    1. Cainap C, Pop LA, Balacescu O, et al. Early diagnosis and screening for lung cancer. Cold Spring Harb Perspect Med. 2021;11:1993–2009. - PMC - PubMed
    1. Chen X, Wang L, Liu J, et al. Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer. Oncol Lett. 2017;13:1609–18. - PMC - PubMed

MeSH terms

Substances